CD8A and neoplasm: Moreover, MC release IL-2 via the IL-33/ST2 pathway, which facilitates the differentiation of CD4+ T cells into ICOS+ regulatory T cells while suppressing the activity of CD8+ T cells, thus fostering tumor progression [40,41].